SPECIAL NOTICE
A -- Notice of National Biosafety Stewardship Month and Health and Safety Requirements for NIH Contractors
- Notice Date
- 8/29/2014
- Notice Type
- Special Notice
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, Division of Acquisition Policy and Evaluation, 6100 Executive Blvd., Room 6C01, Rockville, Maryland, 20892-7540
- ZIP Code
- 20892-7540
- Solicitation Number
- BioSafety
- Point of Contact
- Program on Biosecurity and Biosafety Policy, Phone: 301-496-9838
- E-Mail Address
-
PBBP@od.nih.gov
(PBBP@od.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Notice of National Biosafety Stewardship Month and Health and Safety Requirements for NIH Contractors Purpose Recent reports of lapses in biosafety practices involving Federal laboratories have served to remind us of the importance of constant vigilance over the implementation of biosafety standards. These events potentially put individuals at risk, undermine public confidence in the research enterprise, and must be addressed to prevent their reoccurrence. Efforts to strengthen biosafety oversight and practice must be supported and carried out by organizational leadership, biosafety programs, and individual laboratories. The purpose of this notice is to announce a new biosafety stewardship initiative and to remind institutions of the NIH requirement to meet all applicable Federal, State, and local health and safety standards, as well as the specific terms and conditions of award outlined below. National Biosafety Stewardship Month As a measure toward preventing future lapses as well as promoting stewardship of the life sciences and biosafety awareness across Federal entities, Federal laboratories will reinforce their attention to safe practices in biomedical research. In that regard, the NIH and other HHS agencies will be instituting National Biosafety Stewardship Month, and we urge all NIH contractors to do the same at the local level. During the month of September, NIH laboratories will, and contractors are encouraged to: Reexamine current policies and procedures for biosafety practices and oversight to ascertain whether they require modification to optimize their effectiveness; Conduct inventories of infectious agents and toxins in all laboratories to ensure that the institution has a record of which infectious agents and toxins are being utilized, has documentation that those materials are properly stored under the appropriate containment conditions, and has documentation that cites the party responsible for appropriate stewardship of the materials; and Reinforce biosafety training of investigators, laboratory staff, and members of IBCs to include: •- Reexamining training materials and practices being utilized by the institution; •- Updating materials as appropriate; and •- Ascertaining the appropriate frequency of training and conduct training when the interval between training or other considerations warrant it. NIH contractors are expected to run rigorous programs of biosafety oversight that include attention to safe laboratory practices, training, appropriate policies and procedures. National Biosafety Stewardship Month is an opportunity for you to reinforce what you do in that regard, to optimize further biosafety oversight, and to strengthen your partnership with your investigator community to achieve shared biosafety goals. Your Institutional Biosafety Committees (IBCs) and Biological Safety Officers (BSOs) will have an important role to play in the success of this effort, and NIH will be sending them a letter to encourage their participation. Institutional leadership should do what it can to support IBCs and BSOs in this effort and in the conduct of their duties generally. General Health and Safety Requirements NIH continues to require its contractors to meet applicable Federal, State, and local health and safety standards and for establishing and implementing necessary measures to minimize their employees' risk of injury or illness in activities related to NIH contracts. In addition to applicable Federal, State, and local laws and regulations, the terms and conditions of all NIH contracts require that contractors adhere to the following when developing and implementing health and safety operating procedures and practices for both personnel and facilities: NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The NIH Guidelines articulate biosafety practices, containment measures, and oversight requirements that must be employed by institutions receiving NIH funding for research involving recombinant or synthetic nucleic acid molecules, and apply to all such research regardless of source of funding. The NIH Guidelines may be found at: http://osp.od.nih.gov/office-biotechnology-activities/biosafety/nih-guidelines 29 CFR 1910.1030, Blood borne pathogens; 29 CFR 1910.1450, Occupational exposure to hazardous chemicals in laboratories; and other applicable occupational health and safety standards issued by the Occupational Health and Safety and Health Administration (OSHA) and included in 29 CFR 1910. Moreover, compliance with the regulations will reflect a culture of safety consciousness, accountability, organization, and education. A sound safety organization that is respected by all requires the participation and support of laboratory administrators, workers, and students. A successful health and safety program requires a daily commitment from everyone in the organization. To be most effective, safety and health must be balanced with, and incorporated into, laboratory processes. These regulations are available at http://www.osha.gov/pls/oshaweb/owastand.display_standard_group?p_toc_level=1&p_part_number=1910. Nuclear Regulatory Commission Standards and Regulations, pursuant to the Energy Reorganization Act of 1974 (42 U.S.C. 5801 et seq.). Copies may be obtained from the U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001. The following guidelines are among other resources available for use in developing and implementing health and safety operating procedures and practices for both personnel and facilities: Biosafety in Microbiological and Biomedical Laboratories, CDC and NIH, HHS. This publication is available at http://www.cdc.gov/OD/ohs/biosfty/bmbl5/BMBL_5th_Edition.pdf. Prudent Practices for Safety in Laboratories (1995), National Research Council, National Academy Press, 500 Fifth Street, NW, Lockbox 285, Washington, DC 20055 (ISBN 0-309-05229-7). This publication can be obtained by telephoning 800-624-8373. It also is available at http://www.nap.edu/catalog/4911.html. The signature of the Authorized Organization Representative on the application certifies that the organization will comply with all applicable assurances and certifications referenced in the application. By drawing funds from the HHS payment system, the NIH contractor further agrees to the terms and conditions of the contract award. If requested by NIH, contractors should be able to provide evidence that applicable Federal, State, and local health and safety standards have been considered and have been put into practice. Inquiries Questions about National Biosafety Stewardship Month or adherence to the NIH Guidelines can be directed to: Program on Biosecurity and Biosafety Policy Office of the Director National Institutes of Health Telephone: 301-496-9838 Fax: 301-496-9839 Email: PBBP@od.nih.gov Questions about the NIH Guide Notice or NIH grants requirements: Office of Policy for Extramural Research Administration Office of Extramural Research National Institutes of Health Telephone: 301-435-0949 Fax: 301-435-3059 Email: GrantsInfo@nih.gov
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/DAPE/BioSafety/listing.html)
- Record
- SN03489394-W 20140831/140829235559-4bcffec0155ff780e9ff21002465c0af (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |